159 related articles for article (PubMed ID: 3392656)
21. SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors.
Loudon JM; Bromidge SM; Brown F; Clark MS; Hatcher JP; Hawkins J; Riley GJ; Noy G; Orlek BS
J Pharmacol Exp Ther; 1997 Dec; 283(3):1059-68. PubMed ID: 9399977
[TBL] [Abstract][Full Text] [Related]
22. Application of competition kinetics to investigate rat brain muscarinic receptors.
Schreiber G; Henis YI; Sokolovsky M
Isr J Med Sci; 1987; 23(1-2):36-43. PubMed ID: 3570744
[TBL] [Abstract][Full Text] [Related]
23. Muscarinic acetylcholine receptor in cerebellar cortex participates in acetylcholine-mediated blood depressor response in rats.
Zhou P; Zhu Q; Liu M; Li J; Wang Y; Zhang C; Hua T
Neurosci Lett; 2015 Apr; 593():129-33. PubMed ID: 25797185
[TBL] [Abstract][Full Text] [Related]
24. Regulation of muscarinic acetylcholine receptor concentration in cloned neuroblastoma cells.
Shifrin GS; Klein WL
J Neurochem; 1980 Apr; 34(4):993-9. PubMed ID: 7359145
[No Abstract] [Full Text] [Related]
25. Muscarinic actions and receptor binding of the enantiomers of BM 130, an alkylating analog of oxotremorine.
Ringdahl B; Katz ED; Roch M; Jenden DJ
J Pharmacol Exp Ther; 1989 Apr; 249(1):210-5. PubMed ID: 2709331
[TBL] [Abstract][Full Text] [Related]
26. Cholinergic adaptations to chronic oxotremorine infusion.
Marks MJ; Artman LD; Patinkin DM; Collins AC
J Pharmacol Exp Ther; 1981 Aug; 218(2):337-43. PubMed ID: 7252834
[TBL] [Abstract][Full Text] [Related]
27. Muscarinic M(3) facilitation of acetylcholine release from rat myenteric neurons depends on adenosine outflow leading to activation of excitatory A(2A) receptors.
Vieira C; Duarte-Araújo M; Adães S; Magalhães-Cardoso T; Correia-de-Sá P
Neurogastroenterol Motil; 2009 Oct; 21(10):1118-e95. PubMed ID: 19470085
[TBL] [Abstract][Full Text] [Related]
28. Muscarinic actions of an N-methyl-N-2-bromoethylamino analog of oxotremorine (BR 401) in the mouse.
Ringdahl B; Jenden DJ
J Pharmacol Exp Ther; 1987 Feb; 240(2):370-5. PubMed ID: 3806401
[TBL] [Abstract][Full Text] [Related]
29. Modulation by nicotine on binding of cerebral muscarinic receptors with muscarinic agonist and antagonist.
Wang H; Cui WY; Liu CH
Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):497-9. PubMed ID: 9863140
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneity of release-inhibiting muscarinic autoreceptors in heart atria and urinary bladder: a study with M(2)- and M(4)-receptor-deficient mice.
Zhou H; Meyer A; Starke K; Gomeza J; Wess J; Trendelenburg AU
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):112-22. PubMed ID: 11819029
[TBL] [Abstract][Full Text] [Related]
31. On the effects of diazepam, hyoscine and oxotremorine on acetylcholine release from the cerebral cortex.
Petkov V; Georgiev V; Getova D; Petkov VV
Acta Physiol Pharmacol Bulg; 1983; 9(2):3-13. PubMed ID: 6659979
[TBL] [Abstract][Full Text] [Related]
32. Frequency-dependent muscarinic receptor modulation of acetylcholine and dopamine release from rabbit striatum.
James MK; Cubeddu LX
J Pharmacol Exp Ther; 1984 Apr; 229(1):98-104. PubMed ID: 6707949
[TBL] [Abstract][Full Text] [Related]
33. Lead-induced changes in muscarinic cholinergic sensitivity.
Cory-Slechta DA; Pokora MJ
Neurotoxicology; 1995; 16(2):337-47. PubMed ID: 7566693
[TBL] [Abstract][Full Text] [Related]
34. Pituitary-adrenal responses to oxotremorine and acute stress in male and female M1 muscarinic receptor knockout mice: comparisons to M2 muscarinic receptor knockout mice.
Rhodes ME; Rubin RT; McKlveen JM; Karwoski TE; Fulton BA; Czambel RK
J Neuroendocrinol; 2008 May; 20(5):617-25. PubMed ID: 18363805
[TBL] [Abstract][Full Text] [Related]
35. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
[TBL] [Abstract][Full Text] [Related]
36. Regulation of glutamate release from primary afferents and interneurons in the spinal cord by muscarinic receptor subtypes.
Zhang HM; Chen SR; Pan HL
J Neurophysiol; 2007 Jan; 97(1):102-9. PubMed ID: 17050831
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological characterization of muscarinic receptors mediating inhibition of adenylate cyclase activity in the rat retina.
Qu ZX; Fertel R; Neff NH; Hadjiconstantinou M
J Pharmacol Exp Ther; 1988 Sep; 246(3):839-42. PubMed ID: 2458448
[TBL] [Abstract][Full Text] [Related]
38. Regulation of gamma-aminobutyric acid metabolism in different brain structures by cholinergic and adrenergic drugs.
Balakleevsky AI; Bobrova NP; Shevtchenko NV
Ann Ist Super Sanita; 1978; 14(1):133-8. PubMed ID: 756168
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of muscarinic cholinergic drugs as determined by ex vivo (3H)-oxotremorine-M binding.
Sethy VH; Francis JW
J Pharmacol Methods; 1990 Jul; 23(4):285-96. PubMed ID: 2370805
[TBL] [Abstract][Full Text] [Related]
40. Muscarinic cholinergic receptors in mammalian brain: differences between bindings of acetylcholine and atropine.
Uchida S; Takeyasu K; Ichida S; Yoshida H
Jpn J Pharmacol; 1978 Dec; 28(6):853-62. PubMed ID: 745309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
